ABSTRACT
Peste des petits ruminant (PPR) is an economically important disease of small ruminants with a rapidly expanding geographical distribution. There are fragmented reports to the occurrence and distribution of the disease in Ethiopia. A total of 700 serum samples were collected from goats and sheep to detect the presence of antibody against PPR virus using Competitive Enzyme-Linked Immunosorbent Assay (C-ELISA). An overall PPR seropositivity was reported to be 48.43% in the area. There is no statistically significant difference in the seroprevalence of the disease between sheep and goats (50.85% and 46.68%), respectively. However, there was statistically significant variation (P < 0.05) in the seroprevalence of the disease in young (33.9%) and adult (55.8%) age categories. The seroprevalence in male and female was 42.07% and 50.09%, respectively, where the variation was statistically not significant (P > 0.05). High seroprevalence of Peste des petites ruminants in the study area indicated the virus circulation and endemicity of the disease. The disease causes substantial economic losses by affecting the livelihood of the farmers. Therefore, control measures should be put in place to minimize the loss associated with the disease.
ABSTRACT
Brucellosis is a zoonotic disease with economic and public health impact, particularly for human and animal populations within developing countries that relay on livestock production. A cross sectional study was conducted between October 2013 and March 2014 in and around Alage district to determine the seroprevalence of bovine brucellosis and associated risk factors. A total of 804 sera samples; 421 from cattle managed under extensive production system and 383 from cattle managed under intensive production system were collected. Multistage cluster sampling method was employed to sample unvaccinated cattle above 6 months of age. Rose Bengal Plate Test and c-ELISA were used in serial for detection of antibodies against Brucella species. The overall seroprevalence was 2.4 %, and herd level seroprevalence was 45.9 %. A prevalence of 3.3 and 1.3 % was recorded in the extensive and intensive farms respectively. Among the three sites, seropositivity of 3.4 % in Naka, 3.3 % in Negelewudisha and 1.3 % in Alage were recorded. Risk factors such as age, sex, number of service per conception, calving interval and reproductive status were associated with serostatus of brucellosis. Taken as a whole, cattle in both intensive and extensive production systems are endemically infected by brucellosis at low level in the study areas. This warrants the need of integrated intervention strategies to minimize the spread of the disease in animals and reduce the risk of transmission to humans.
ABSTRACT
The safety, immunogenicity and efficacy of three commercially available vaccines against lumpy skin disease (LSD) in cattle have been evaluated using a combination of vaccine challenge experiments and the monitoring of immune responses in vaccinated animals in the field. The three vaccines evaluated in the study included two locally produced (Ethiopian) vaccines (lumpy skin disease virus (LSDV) Neethling and Kenyan sheep and goat pox (KSGP) O-180 strain vaccines) and a Gorgan goat pox (GTP) vaccine manufactured by Jordan Bio-Industries Centre (JOVAC). The latter vaccine was evaluated for the first time in cattle against LSDV. The Ethiopian Neethling and KSGPO-180 vaccines failed to provide protection in cattle against LSDV, whereas the Gorgan GTP vaccine protected all the vaccinated calves from clinical signs of LSD. There was no significant difference in protective efficacy detected between two dosage levels (P=0.2, P=0.25, and P=0.1 for KSGP, Neethling and Gorgan vaccines, respectively). Additionally, the Gorgan GTP vaccinated cattle showed stronger levels of cellular immune responses measured using Delayed-Type Hypersensitivity (DTH) reactions at the vaccination site indicating higher levels of immunogenicity produced by the GTPV vaccine in cattle, as opposed to the other two vaccines. This study indicated, for the first time, that the Gorgan GTP vaccine can effectively protect cattle against LSDV and that the Neethling and KSGP O-180 vaccine were not protective. The results emphasise the need for molecular characterization of the Neethling and KSGP O-180 vaccine seed viruses used for vaccine production in Ethiopia. In addition, the potency and efficacy testing process of the Ethiopian LSD Neethling and KSGP O-180 vaccines should be re-evaluated.
